Watch ZURA. Know when insiders buy.
One email the day a filing lands. Free.
ZURA
Zura Bio Ltd
4.11
−0.03 −0.72%
USD · close Oct 2
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
58
WATCH · shorts 58
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $393.9MP/E —DIV YIELD —FCF YIELD -16.49%REV TTM —NET INCOME −$85.7MNET CASH —52W 3.21 – 7.04SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$29.3M | −$26.3M | — | -0.21 | $18.9M | −$13K | $18.9M | Aug 11 |
| Q1 2026 · Mar 31 | — | — | — | −$25.5M | −$24.2M | — | -0.22 | −$18.9M | $13K | −$18.9M | May 7 |
| Q4 2025 · Dec 31derived | — | — | — | −$18.4M | −$17.2M | — | -0.49 | −$22.3M | $17K | −$22.3M | Mar 19 |
| Q3 2025 · Sep 30 | — | — | — | −$19.5M | −$18M | — | -0.21 | −$42.5M | $96K | −$42.6M | Nov 13 |
| Q2 2025 · Jun 30 | — | — | — | −$18.1M | −$16M | — | -0.17 | $11M | −$49K | $11.1M | Aug 11 |
| Q1 2025 · Mar 31 | — | — | — | −$19.3M | −$17.4M | — | -0.19 | −$11.1M | $49K | −$11.1M | May 7 |
| Q4 2024 · Dec 31derived | — | — | — | −$15.7M | −$13.6M | — | -0.08 | −$10.8M | $45K | −$10.9M | Mar 19 |
| Q3 2024 · Sep 30 | — | — | — | −$19.3M | −$20.7M | — | -0.26 | −$5.7M | $13K | −$5.7M | Nov 13 |
| Q2 2024 · Jun 30 | — | — | — | −$11.8M | −$10.3M | — | -0.17 | −$6.6M | $10K | −$6.6M | Aug 14 |
| Q1 2024 · Mar 31 | — | — | — | −$8.4M | −$7.7M | — | -0.02 | −$5M | $7K | −$5M | May 8 |
| Q4 2023 · Dec 31derived | — | — | — | −$10.8M | −$8.5M | — | 0.13 | −$4.1M | — | — | Mar 25 |
| Q3 2023 · Sep 30 | — | — | — | −$10.2M | −$8.3M | — | -0.18 | −$2.6M | — | — | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$75.2M | −$68.7M | — | -1.06 | −$64.8M | $113K | −$64.9M | — | — |
| FY2024 · to Dec 31 | — | — | −$55.2M | −$52.4M | — | -0.60 | −$28.1M | $75K | −$28.2M | — | — |
| FY2023 · to Dec 31 | — | — | −$62.6M | −$60.4M | — | -2.09 | −$15.1M | — | — | — | — |
| FY2022 · to Dec 31 | — | — | −$27.2M | −$25.7M | — | -141.97 | −$1.2M | — | — | — | — |
Every number comes from Zura Bio Ltd's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.